Aurora Cannabis (ACB) Other financing activities (2018 - 2024)
Aurora Cannabis (ACB) posted quarterly Other financing activities of $39371.7 for Q4 2024, up 155.26% year-on-year from $15424.2 in Q1 2024, and up 141.0% on a QoQ basis from -$96030.0 in Q3 2024.
Aurora Cannabis (ACB) Other financing activities (2018 - 2024) Analysis & Trends
Aurora Cannabis (ACB) has reported Other financing activities for 7 consecutive years, with $39371.7 the latest figure, recorded in Q4 2024.
- Quarterly Other financing activities rose 155.26% year-over-year to $39371.7 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$784472.5 (up 91.69% YoY) and the FY2023 annual result came in at -$66256.3, up 99.73% from the prior year.
- Other financing activities climbed to $39371.7 in Q4 2024 per ACB's latest filing, from -$96030.0 in the prior quarter.
- Over the last five years, Other financing activities for ACB reached as high as $26.0 million in Q1 2022 and fell as low as -$25.5 million in Q3 2021.
- A 5-year average of -$863321.4 and a median of -$83640.0 in 2023 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2020 — Other financing activities sank 35732.82% — and 2023, when it jumped 1189.97%.
- Year by year, Other financing activities stood at -$2.4 million in 2020, then surged by 105.26% to $127727.1 in 2021, then tumbled by 8366.97% to -$10.6 million in 2022, then surged by 99.33% to -$71249.9 in 2023, then surged by 155.26% to $39371.7 in 2024.
- According to Business Quant data, Other financing activities over the past three periods registered $39371.7, -$96030.0, and -$656564.2 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 155.40 Mn | 70.15 Mn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 39,371.70 |
| Dec 31, 2024 | 39,371.70 |
| Sep 30, 2024 | -96,030.00 |
| Sep 30, 2024 | -96,030.00 |
| Jun 30, 2024 | -656,564.21 |
| Jun 30, 2024 | -656,564.21 |
| Dec 31, 2023 | -71,249.95 |
| Dec 31, 2023 | -71,249.95 |
| Sep 30, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Dec 31, 2022 | -10.56 Mn |
| Dec 31, 2022 | -10.56 Mn |
| Sep 30, 2022 | -120,379.16 |
| Sep 30, 2022 | -120,379.16 |
| Jun 30, 2022 | -66,668.96 |
| Jun 30, 2022 | -66,668.96 |
| Mar 31, 2022 | 25.99 Mn |
| Mar 31, 2022 | 25.99 Mn |
| Dec 31, 2021 | 127,727.11 |
| Dec 31, 2021 | 127,727.11 |